Concept and feasibility assessment for AnandaCor, a fast melting tablet, as a diagnostic device in ischemic heart conditions.

Project Information

AnandaCor

Grant agreement ID: 685218

DOI 10.3030/685218

Project closed

EC signature date 10 June 2015

Start date 1 July 2015

End date 31 December 2015

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 71 429,00

EU contribution € 50 000,00

Coordinated by

ANANDA PHARMA GMBH
Germany